Evidence map›Paper›PMID 36810349›Full record

ArticleEuropean journal of hospital pharmacy : science and practice2023

Implementation of pharmacists' monitoring for intravenous drug compatibility.

Young Ju Cheon, Kyong Nam Ye, Kyong Ha Park, Jung Bo Kim, Ji Eun Yoon, Min Kyung Lee, Jung Tae Kim, Sook Hee An

Open access · greenAbstract read
In one paragraph

Article in European journal of hospital pharmacy : science and practice, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Young Ju CheonDepartment of Pharmacy, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Kyong Nam YeDepartment of Pharmacy, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Kyong Ha ParkONESglobal Inc, Seoul, South Korea.
Jung Bo KimDepartment of Pharmacy, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Ji Eun YoonDepartment of Pharmacy, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Min Kyung LeeDepartment of Pharmacy, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Jung Tae KimDepartment of Pharmacy, Kyung Hee University Hospital at Gangdong, Seoul, South Korea.
Sook Hee AnCollege of Pharmacy, Wonkwang University, Iksan, Jeollabuk-do, South Korea shan7@wku.ac.kr.ORCID 0000-0002-7552-0233
Kyung Hee University Hospital at Gangdong · KRWonKwang Health Science University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInjectable medication errors primarily occur during preparation and administration. Currently, South Korea is experiencing chronic pharmacist shortages. Moreover, pharmacists have not routinely conducted prescription monitoring for intravenous compatibility. In the present study, we analysed the implementation of a pre-issue monitoring program using recently released cloud-based software to provide information on intravenous compatibility in the pharmacy at a general hospital in South Korea.

objectivesThe aims of this study were to determine whether adding an intravenous drug prescription review to pharmacists' actual work scope could promote patient safety, and to assess the impact of this new task on pharmacists' workload.

methodsData on intravenous drugs prescribed in the intensive care unit and haematology-oncology ward were prospectively collected during January 2020. Four quantitative items were evaluated: the run-time, intervention ratio, acceptance ratio, and the information completeness ratio with regard to the compatibility of intravenous drugs.

resultsThe mean run-time of two pharmacists was 18.1 min in the intensive care unit and 8.7 min in the haematology-oncology ward (p<0.001). Significant differences were also found between the intensive care unit and the haematology-oncology wards in terms of the mean intervention ratio (25.3% vs 5.3%, respectively; p<0.001) and the information completeness ratio (38.3% vs 34.0%, respectively; p=0.007). However, the mean acceptance ratio was comparable (90.4% in the intensive care unit and 100% in the haematology-oncology ward; p=0.239). The intravenous pairs that most frequently triggered interventions were tazobactam/piperacillin and famotidine in the intensive care unit, and vincristine and sodium bicarbonate in the haematology-oncology ward.

conclusionThis study suggests that despite a shortage of pharmacists, intravenous compatibility can be monitored before issuing injectable products in all wards. Because the prescribing pattern of injections varies across wards, pharmacists' tasks should be established accordingly. To improve the completeness of information, efforts to generate more evidence should continue.

Indexed as

PharmacistsPharmacy Service, HospitalHospitalsHumansMedication ErrorsPatient Safetyadministration, intravenousdrug incompatibilitydrug monitoringpharmacy service, hospitalsafety

Identifiers

PMID36810349
PMCPMC9986928
OpenAlexW4294044058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.